volume 17 | number 12 | DeCember 2014 nature neuroscience a r t i c l e s which catalyzes dimethylation of histone H3 lysine 9 (H3K9me2), a repressive histone modification 12 , appears to be crucial for mediating this regulation: H3K9me2 enrichment at Fosb is suppressed in the NAc by repeated cocaine 12 , and we found increased levels of H3K9me2 at FOSB in the NAc of depressed humans. Moreover, we previously found that local overexpression or knockdown of G9a in NAc potently controls drug and stress responses in rodents 11, 12 . Nevertheless, this quality of proof is inherently limited because drugs and stress, as well as G9a manipulations, affect H3K9me2 enrichment at hundreds of loci in this brain region 1, 12, 13 . These previous studies underscore the fact that all of the current evidence for the epigenetic basis of reward pathology has relied on correlating the effects of global manipulations of histone post-translational modifications (HPTMs) with affected behavior and physiology, resulting in a limited analysis of the transcriptional mechanisms linking epigenetic modifications at a single gene to the transcriptional activity of that gene and subsequent reward behavior.
a r t i c l e s which catalyzes dimethylation of histone H3 lysine 9 (H3K9me2), a repressive histone modification 12 , appears to be crucial for mediating this regulation: H3K9me2 enrichment at Fosb is suppressed in the NAc by repeated cocaine 12 , and we found increased levels of H3K9me2 at FOSB in the NAc of depressed humans. Moreover, we previously found that local overexpression or knockdown of G9a in NAc potently controls drug and stress responses in rodents 11, 12 . Nevertheless, this quality of proof is inherently limited because drugs and stress, as well as G9a manipulations, affect H3K9me2 enrichment at hundreds of loci in this brain region 1, 12, 13 . These previous studies underscore the fact that all of the current evidence for the epigenetic basis of reward pathology has relied on correlating the effects of global manipulations of histone post-translational modifications (HPTMs) with affected behavior and physiology, resulting in a limited analysis of the transcriptional mechanisms linking epigenetic modifications at a single gene to the transcriptional activity of that gene and subsequent reward behavior.
We sought to achieve a stronger level of proof using engineered transcription factors, zinc-finger proteins (ZFPs) 14 or transcription activatorlike effectors (TALEs) 15 that can be designed in silico to recognize and bind to a specific 18-20-bp locus in the genome. Fusion of the DNAbinding domain to a given catalytic domain allows gene-targeted transcriptional regulation at the site of interest. ZFPs and TALEs have been applied in vitro and have been shown to efficiently activate or repress gene expression when fused to any of several functional domains.
Drug addiction and depression are associated with altered expression or activity of particular transcription factors and histone-modifying enzymes in both rodent models and human patients; experimental manipulation of such molecules in discrete brain regions alters the cellular and behavioral responses to drug or stress exposures in animals [1] [2] [3] [4] . Studies of the mechanisms underlying altered gene expression in response to drugs or stress have involved analyses of transcription factor binding and enrichment of modified histones throughout the genome 5, 6 . Notably, despite global enrichment in histone acetylation and depletion in histone methylation in a given brain region, many genes show alterations opposite to these, posing a key question as to the mechanism and relevance of genespecific chromatin remodeling in the context of drug-and stress-evoked epigenetic changes. Although work to date has laid the foundation for investigating the role of such histone modifications in the regulation of drug or stress responses, previous approaches have lacked the specificity needed to demonstrate the causal mechanisms by which a given chromatin modification at a specific gene is necessary and sufficient to regulate drugor stress-evoked transcriptional and behavioral plasticity.
To overcome this limitation, we focused on the transcription factor ∆FosB acting in the nucleus accumbens (NAc), a key brain reward region, during drug and stress action 7, 8 . ∆FosB is induced in the NAc by chronic cocaine exposure in rodents and in human cocaine addicts 4, 9 , but its expression is reduced by certain forms of chronic stress in rodents and in depressed humans 10, 11 . The histone methyltransferase G9a (EHMT2), Locus-specific epigenetic remodeling controls addiction-and depression-related behaviors a r t i c l e s induced by HSV-Fosb-ZFP35-p65 compared with control virus (Fosb, t 7 = 2.37, *P = 0.049; DFosb, t 7 = 3.83, *P = 0.007; n = 4, 5 mice per group), with a trend for ∆Fosb induction by Fosb-ZFP61-p65 (t 7 = 2.03, # P = 0.076; n = 4, 5). Compared with controls, Fosb/∆Fosb mRNA in the NAc were significantly repressed by HSV-Fosb-ZFP35-G9a (Fosb, t 6 = 4.84, *P = 0.003; DFosb, t 6 = 3.40, *P = 0.015; n = 5, 3), HSV-Fosb-ZFP61-NFD (Fosb, t 7 = 2.39, *P = 0.048; n = 4), and Fosb-ZFP61-G9a (Fosb, t 8 = 2.98, *P = 0.017; DFosb, t 8 = 2.37, *P = 0.047; n = 5, 5), with a trend for repression of ΔFosB by Fosb-ZFP61-NFD (ΔFosb, t 7 = 2.18, # P = 0.066, n = 5). HSV-G9a, HSV-p65, HSV-Klf4-ZFP-p65, HSV-VEGF-ZFP-G9a and HSV-Fosb-ZFP35-NFD had no effect on Fosb/∆Fosb mRNA expression (Student's unpaired t test, P > 0.05 for all other comparisons; Supplementary Table 3) . (e) Compared with HSV-Fosb-ZFP35-NFD (n = 9 ChIP samples), NAc injection of HSV-Fosb-ZFP35-p65 resulted in increased FosB/DFosB protein levels (FosB, t 13 = 3.73, *P = 0.003; DFosB: t 13 = 6.65, *P = 0.000; n = 6), whereas HSV-Fosb-ZFP35-G9a had no effect at 72 h post-injection (FosB, t 14 = 0.137, P = 0.8929; DFosB, t 14 = 1.25, P = 0.230; n = 8). Representative western blots are shown. Full-length western blots are shown in Supplementary Figure 5 . (f) NAc injection of HSV-Fosb-ZFP35-p65 caused enrichment of the activating mark H3K9/14ac at the Fosb promoter at -1,250 (t 8 = 2.65, *P = 0.029, n = 5, 5 ChIP samples) and -250 bp (t 8 = 2.9, *P = 0.021, n = 5, 5) relative to the TSS compared with control HSV, with no change in tissue treated with HSV-Fosb-ZFP35-NFD (t 10 = 0.00, P = 1.00; n = 6, 6) or at the Fos promoter (t 7 = 0.217, P = 0.834; n = 5, 4). IgG control IP was undetectable in >80% of the sample wells by qRT-PCR. (g) NAc injection of HSV-Fosb-ZFP35-G9a caused enrichment of the repressive mark H3K9me2 at the Fosb promoter at -1,250 (t 26 = 2.7, *P = 0.011, n = 14, 14 ChIP samples), -500 (t 14 = 2.3, *P = 0.041, n = 7, 9) and -250 bp (t 13 = 2.9, *P = 0.031, n = 7, 8) relative to the TSS compared with control HSV, with no change in tissue treated with HSV-Fosb-ZFP35-NFD (-1,250, t 19 = 0.45, P = 0.658, n = 14, 7; -500, t 8 = 0.03, P = 0.977, n = 7, 3; -250, t 9 = 1.51, P = 0.167, n = 8, 3) or at the Fos promoter (t 16 = 0.42, P = 0.680 n = 7, 11). IgG control immunoprecipitation was undetectable in >80% of the sample wells by qPCR. (h) NAc injection of HSV-Fosb-ZFP35-G9a caused enrichment of H3K9me2 (t 19 = 2.4, *P = 0.0238, n = 5, 5) depletion of the repressive mark H3K9me3 (t 8 = 3.3, *P = 0.011, n = 5, 5 ChIP samples) and enrichment of HP1a (t 7 = 2.5, *P = 0.039, n = 4, 4) at the Fosb promoter -1,250 bp upstream from the TSS compared with control HSV-Fosb-ZFP35-NFD. (i) Bisulfite sequencing analysis performed on three CpG sites located -1,141, -1,101 and -1,036 bp upstream of the Fosb TSS, in a region that corresponds to the observed H3K9me2 and HP1a enrichment (a). There was no difference in the percentage of methylated CpGs in NAc infected with HSV-Fosb-ZFP35-G9a (n = 19 clones) compared with HSV-Fosb-ZFP35-NFD (n = 23). Each row represents analysis performed on one clone. Data are presented as mean ±s.e.m. (Fig. 1g) . Notably, H3K9me2 was not enriched at the promoter of the related immediate early gene Fos (Fig. 1f,g ), nor was H3K9me2 enriched globally in total NAc extracts (H3K9me2: t 1,15 = 1.35, P = 0.20, n = 8 NFD, n = 9 G9a). Taken together, these results demonstrate that viral expression of engineered ZFPs efficiently enrich their respective HPTMs at the Fosb promoter and bi-directionally control Fosb gene expression in vivo.
The analysis of control constructs was critical to our investigation, as both a ZFP with NFD 28 or the functional domain alone 29 may have nonspecific effects on transcription. We found that neither the p65 nor G9a domains alone regulated expression of Fosb when virally expressed in the NAc (Fig. 1d) . Furthermore, ZFPs targeted to unrelated genes, Klf4-ZFP-p65 and Vegf-ZFP-G9a, did not affect Fosb/DFosb expression in the NAc (Fig. 1d) . Finally, NAc expression of HSV-Fosb-ZFP35-NFD had no effect on Fosb/DFosb mRNA levels (Fig. 1d) or on enrichment of HPTMs at the Fosb promoter (Fig. 1f,g ). We did find that Fosb-ZFP61-NFD repressed Fosb expression (Fig. 1d) , perhaps because its binding site is just downstream of the TSS (Fig. 1a) , and we therefore excluded this ZFP from further study.
To determine the specificity of Fosb gene regulation by Fosb-ZFP35, we examined the mouse genome for 19-bp motifs that differed from the ZFP35-binding motif by one, two or three nucleotides and were located in 3 kb of a TSS (no site shared the identical 19-bp sequence; Supplementary Table 2 ) and we found 28 off-target genes. Using qRT-PCR, we found that the expression of these 28 off-target genes was unaffected by NAc expression of HSV-Fosb-ZFP35-p65, HSV-Fosb-ZFP35-G9a or HSV-Fosb-ZFP35-NFD (22 genes) or was undetectable (6 genes) (Fig. 2b) . Finally, we selected those loci located within 1,000 bp upstream of their respective TSSs and found that HSV-Fosb-ZFP35-G9a in NAc did not alter H3K9me2 binding at any of these six off-target sites (Fig. 2c) . This detailed analysis of specificity goes further than previous studies to assess the off-target regulation by ZFPs in vivo. Nonetheless, we cannot rule out the possibility of undetected off-target regulation of additional genes that may contribute to the transcriptional and behavioral changes induced by Fosb-ZFP35-G9a or Fosb-ZFP35-p65. On the basis of this detailed characterization, we focused on Fosb-ZFP35.
Mechanisms of action of Fosb-ZFP-G9a in NAc
To investigate the potential mechanism by which enrichment of H3K9me2 in Fosb promoter regulates expression of Fosb/DFosb, we examined additional histone modifications and histone-binding proteins that may contribute to gene repression. We found that expression of HSV-Fosb-ZFP-G9a in NAc did not alter enrichment of tri-methylated histone H3 lysine 27 (H3K27me3) or histone H3 lysine 4 (H3K4me3), which are repressive and activating marks, respectively, at the Fosb gene (Fig. 2) . We next examined two marks that have been strongly implicated in repression, acting in concert with H3K9me2, tri-methylated histone H3 lysine 9 (H3K9me3) and heterochromatin protein 1a (HP1a) 30, 31 . We found that HSV-Fosb-ZFP-G9a in NAc decreased the levels of H3K9me3, but induced a ~2-fold enrichment of HP1a, at the Fosb promoter compared with HSV-Fosb-ZFP-NFD (Fig. 1h) . However, the level of H3K9me3 and HP1a binding to Fosb was nearly an order of magnitude below that of H3K9me2, raising the possibility that other factors are primarily involved in mediating Fosb repression associated with increased H3K9me2 at euchromatic regions in adult brain. Notably, both H3K9me3 depletion and HP1a enrichment were detected only at a site ~1,200 bp upstream from the Fosb TSS, which we found to be the major site of enrichment of H3K9me2 in response to HSV-Fosb-ZFP35-G9a (Fig. 1g) and under physiological conditions in both mouse 12, 13 and human NAc (Fig. 3g) . This site is ~1,000 bp upstream of the ZFP35 binding site (Fig. 1a) , suggesting that the binding of G9a to a proximal More recently, ZFPs and TALEs have been used in vitro to promote epigenetic remodeling when fused to chromatin-modifying enzymes 14, 16, 17 . Although very few studies to date have used this approach in vivo, one study showed reversal of a Parkinsonian phenotype in a mouse model by overexpression of a ZFP-transcriptional activator directed against the promoter of glial cell line-derived neurotrophic factor (Gdnf), which conferred protection from a striatal chemical lesion 18 . We took advantage of this approach to investigate the causal role of cocaine-and stress-evoked epigenetic regulation of the Fosb locus in the NAc in vivo.
RESULTS

Generation of ZFPs that target the Fosb gene in vivo
To direct locus-specific epigenetic changes to a specific gene, we screened a suite of cys2-his2 six-finger ZFPs 19 for regulation of Fosb transcription, designed in silico to span the murine Fosb promoter at various 18-20-bp motifs within -1,000 to +200 bp relative to the transcription start site (TSS) (Fig. 1) . As an initial proof of principle, each ZFP was fused to the p65 domain of the mammalian transcription factor NFkB, which activates transcription by promoting histone acetylation via recruitment of p300/ CBP (CREB-binding protein) 20 . Histone acetylation has been shown to modulate drug-and stress-evoked behavior [21] [22] [23] and gene expression 1, 24 , in part by regulating drug-associated memory formation 25, 26 . A subset of the Fosb-ZFP-p65 constructs were transfected into Neuro2a (N2a) cells and their relative efficacy was determined by quantitative reverse transcription PCR (qRT-PCR) analysis of Fosb/∆Fosb mRNA expression ( Supplementary Fig. 1 ). ZFP25, ZFP35 and ZFP61 were selected as potent activators of Fosb transcription and subjected to further analysis. To study regulation of the Fosb gene in vivo, we injected mouse NAc ( Fig. 1b and Supplementary Fig. 2a ) with herpes simplex virus (HSV) vectors expressing various Fosb-ZFP-p65 or Fosb-ZFP-NFD (no functional domain) constructs and quantified Fosb/∆Fosb mRNA using qRT-PCR.
We found that HSV-Fosb-ZFP35 and HSV-Fosb-ZFP65-p65 constructs activated transcription of Fosb/∆Fosb in the NAc relative to HSV-GFP or HSV-NFDs (Fig. 1d) . To address the mechanism of the repressive histone mark H3K9me2 in the regulation of Fosb expression, we generated Fosb-ZFP-G9a constructs, in which each of three distinct ZFPs was fused to the minimal catalytic domain of G9a 14, 27 . HSV delivery of Fosb-ZFP35-G9a or Fosb-ZFP61-G9a to the NAc efficiently repressed Fosb/∆Fosb mRNA expression (Fig. 1d) . The changes in the amount of Fosb/DFosb mRNA that we observed in the NAc were physiologically relevant and were similar in magnitude to drug-and stress-induced changes observed previously 1, 24 . In addition to regulation of basal mRNA expression, we found by immunoblotting that FosB/DFosB protein was elevated in NAc expressing HSVFosb-ZFP35-p65 (Fig. 1e) , whereas there was no effect in NAc infected with HSV-Fosb-ZFP35-G9a relative to the HSV-Fosb-ZFP35-NFD at 72 h post infection. To more carefully examine Fosb repression by HSVFosb-ZFP35-G9a, we performed immunohistochemistry and found that the percentage of FosB/DFosB-immunopositive cells decreased markedly as a percentage of HSV-infected (GFP + ) cells in NAc infected with HSV-Fosb-ZFP35-G9a compared with a control vector ( Supplementary  Fig. 2b ). These findings confirm that the ZFPs were exerting their function in the HSV-infected neurons that expressed FosB/DFosB.
The ability to site-specifically regulate chromatin architecture enables direct examination of the function of HPTMs in regulating gene transcription in the brain. We used semiquantitative chromatin immunoprecipitation (qChIP; Supplementary Table 1) and found enrichment of the activating histone modification, H3K9/K14 acetylation, at the Fosb promoter (Fig. 1f) in NAc infected with HSV-Fosb-ZFP35-p65, an effect that was not observed in NAc infected with HSV-Fosb-ZFP35-G9a (Fig. 2a) . Conversely, NAc infection with HSV-Fosb-ZFP35-G9a led to the enrichment of the repressive histone modification H3K9me2 npg a r t i c l e s induction (Fig. 3b,c) . At this time point (7 d after HSV injection), HSVmediated transgene expression had fully dissipated; thus, it was not possible to selectively examine the infected cells, which likely accounts for the fact that expression of FosB/DFosB in saline-treated mice was not affected by HSV-Fosb-ZFP35-G9a (Fig. 3b,c) .
To further our understanding of cocaine-regulated Fosb expression, we sought to discover a molecular mechanism by which an increase in H3K9me2 solely at the Fosb promoter blocks cocaine induction of FosB/ DFosB protein in vivo. We reasoned that this repressive histone modification might interfere with activation (that is, phosphorylation) of cAMP response element-binding protein (phospho-CREB(S133)) and/or serum response factor (phospho-SRF(S103)), both of which are required for Fosb induction in the NAc by repeated cocaine 32 . We injected mouse NAc with either control HSV or HSV-Fosb-ZFP35-G9a and then treated the animals with either repeated saline or cocaine (20 mg per kg). qChIP revealed that cocaine treatment resulted in a 3.9-fold enrichment of phospho-CREB at the Fosb promoter compared with saline-treated mice (Fig. 3d) . This enrichment was blocked by NAc injection of HSV-Fosb-ZFP35-G9a (Fig. 3d) . As previously demonstrated 32 , cocaine had no effect on the enrichment of total CREB protein at the Fosb promoter, and HSV-Fosb-ZFP35-G9a did not alter levels of total CREB binding (Fig. 3e) . Notably, cocaine treatment caused enrichment of phospho-SRF binding at the Fosb promoter, but there was only a modest effect of HSV-Fosb-ZFP35-G9a (Fig. 3f) , site on the Fosb promoter induces a spreading repressive mechanism that affects a relatively large span of the Fosb gene. Based on these findings, we further investigated an additional epigenetic signature, DNA methylation. Although we observed methylation of the three predicted CpG sites in this ~1,200-bp region of Fosb by bisulfite conversion, there was no effect of HSV-Fosb-ZFP35-G9a (Fig. 1i) . Notably, the site targeted by ZFP35 coincides with a region in which we previously observed regulation of endogenous G9a binding in response to cocaine treatments 12 , supporting the physiological relevance of Fosb-ZFP35-G9a action in regulating Fosb expression and the potential use of this tool for understanding mechanisms controlling Fosb expression in vivo.
Given that cocaine-induced DFosB protein accumulation contributes to the addiction phenotype, we sought to interfere with this physiological response by inducing H3K9me2 specifically at the Fosb locus (Fig. 3) . Mice were injected with HSV-Fosb-ZFP35-G9a and HSV-Fosb-ZFP35-NFD in the right and left NAc, respectively, and then treated with repeated saline or cocaine (20 mg per kg of body weight) over a time course designed to coincide with HSV expression (72 h) while remaining sufficiently long enough to lead to FosB/DFosB protein accumulation in NAc (Fig. 3a) . Immunohistochemical analysis using an antibody to FosB/DFosB revealed that, although cocaine increased the number of FosB-immunopositive NAc neurons by 39% in NAc infected with control virus, expression of HSV-Fosb-ZFP35-G9a blocked this Table 2 ) in samples that showed regulation of FosB/DFosB by HSV-Fosb-ZFP35-p65 (FosB, t 7 = 4.73, *P = 0.002; DFosB, t 7 = 4.83, *P = 0.002; n = 4, 5 mice) and HSV-Fosb-ZFP35-G9a (FosB, t 8 = 2.40, *P = 0.043; DFosB, t 8 = 2.88, *P = 0.021; n = 5, 5), but not HSV-Fosb-ZFP35-G9a (FosB: t 8 = 0.38, P = 0.715; DFosB: t 8 = 0.52, P = 0.619; n = 5, 5). Data were normalized to HSV-GFP (Student's unpaired t test, P > 0.05 for all other comparisons; Supplementary Table 3 Fig. 1 ), but repressed expression in NAc neurons in vivo (Fig. 1d) . To investigate a potential explanation for these discrepancies, we compared the expression level of ZFP constructs in vitro versus in vivo and found several orders of magnitude greater expression in N2a cells than in NAc (Supplementary Fig. 4a ). However, titration of the amount of Fosb-ZFP35-G9a expressed in N2a cells affected the expression of DFosb, but not Fosb, mRNA, indicating that ZFP expression levels account for only a part of its distinct function in vitro and in vivo (Supplementary Fig. 4b ). An alternative explanation is provided by the fact that chromatin state is a major determinant of transcription factor binding and function and that such states differ between cell types 34, 35 . These data underscore the importance of our approach in using an in vivo system to characterize engineered transcription factors as tools to study epigenetic mechanisms of gene regulation in reward regions of mammalian brain.
Regulation of reward behavior by Fosb-ZFPs
Having established a mechanism by which engineered transcription factors can specifically regulate DFosB expression in vivo, we next investigated their ability to modulate reward behaviors, starting with the regulation of cocaine action (Fig. 4) . Mice were injected intra-NAc with HSV-Fosb-ZFP35, HSV-Fosb-TALE1 or control vectors and their locomotor activity was recorded over several days of cocaine treatment at either a sensitizing dose (10 mg per kg) or a subthreshold dose (5 mg per kg) that does not lead to locomotor sensitization in control animals ( Fig. 4a and Supplementary Fig. 3e ). We found that HSV-Fosb-ZFP35-G9a expression in NAc efficiently blocked cocaine locomotor sensitization (10 mg per kg; Fig. 3c ), whereas both HSV-Fosb-ZFP35-p65 and HSV-TALE1-VP64 augmented the sensitizing effects of the drug, despite the close proximity of the CREB and SRF binding sites (Fig. 1a) .
We also examined the enrichment of HP1a at the Fosb promoter and found that, although cocaine did not regulate binding of this protein to Fosb in NAc, HSV-Fosb-ZFP35-G9a expression led to enrichment of HP1a in either the cocaine or saline context (Fig. 3g) , as shown earlier (Fig. 1h ). These data demonstrate that, in fully differentiated adult neurons in vivo, a primary increase in H3K9me2 at a given gene controls enrichment of an activated transcription factor at that gene and the gene's expression in response to an environmental stimulus.
Regulation of Fosb by transcription activator-like effectors
To gain a broader understanding of transcriptional regulation by engineered transcription factors, we targeted the Fosb gene with TALEs 17,33 , a distinct type of designer DNA binding domain, as well as with a variety of transcriptional activators, including VP64, VP16 and 2xp65 (Supplementary Fig. 3 ). Fosb TALEs fused to the transactivator VP64 efficiently upregulated expression of Fosb/DFosb when virally expressed in the NAc, whereas Klf4-TALE-VP64 had no effect ( Supplementary  Fig. 3b) . Furthermore, VP16, VP64 and 2xp65 activated Fosb/DFosb expression when fused to Fosb-ZFP35 and expressed in N2a cells (Supplementary Fig. 3d) . Such a comprehensive analysis demonstrated that engineered transcription factors are potent, bidirectional regulators of FosB/DFosB expression, yet we also found that their effect in cell culture was not always an accurate predictor of their function in brain. For example, Fosb-ZFP25-p65 robustly activated Fosb/DFosb expression in N2a cells (Supplementary Fig. 1 ) but failed to activate transcription when expressed in NAc neurons in vivo (Fig. 1d) . We also observed that several Fosb-ZFP-G9a constructs activated Fosb expression in N2a cells 
a r t i c l e s
Recent evidence has also implicated a reduction of DFosB levels in the NAc in the etiology of depression in humans and in chronic stress models in rodents 8 . Indeed, we found that depressed human NAc exhibited a 37% enrichment of H3K9me2 at the FOSB promoter (Fig. 3g) , specifically at a with no effect of HSV-Fosb-ZFP35-NFD (5 mg per kg; Fig. 4d,e and  Supplementary Fig. 3e) . None of the constructs affected baseline locomotor activity seen in the absence of cocaine compared with control virus (Fig. 4c-e and Supplementary Fig. 3e ). 
(i) HSV-
Fosb-ZFP35-G9a in the NAc blocked increased exploration of a novel aggressor mouse after exposure to subthreshold social defeat, compared with control virus (t 12 = 3.1, *P = 0.009, n = 7 mice per group) with no effect of HSV-Fosb-ZFP35-NFD (t 12 = 3.2, *P = 0.008, n = 7). (j) Representative heat maps of social interaction after a subthreshold defeat stress showed a preference for the interaction zone when a target mouse was present for mice injected with control virus and HSV-Fosb-ZFP35-NFD, but not HSV-Fosb-ZFP35-G9a. Data are presented as mean ±s.e.m. npg a r t i c l e s no genome-wide transcription regulation by gene-targeted engineered transcription factors 17, 37, 38 . Our data are, to the best of our knowledge, the first to demonstrate the functional specificity of engineered transcription factors in neurons in vivo, thereby greatly enhancing their use for the study of the epigenetic underpinnings of neuropsychiatric disease. Previous studies have demonstrated the dynamic regulation of histone methylation by both chronic cocaine and stress 11, 12 . In particular, repeated cocaine treatment reduces G9a expression and the enrichment of H3K9me2 in the NAc, resulting in derepression at hundreds of genes, including Fosb; viral overexpression of G9a in NAc increases H3K9me2 at Fosb, represses DFosB expression and inhibits cocaine reward behavior 12 . Our results improve on this previous approach by targeting G9a specifically to the Fosb gene, thereby arguing against effects of G9a across the genome and directly implicating G9a-induced H3K9me2 at Fosb in the specific mechanism of Fosb gene repression.
Histone methylation is thought to repress gene expression via the recruitment of additional methyltransferases and HP1, which can lead to the formation of silent heterochromatin 30, 39 . We found that Fosb-ZFP35-G9a induced H3K9me2 enrichment across the Fosb promoter, up to 1,000 bp upstream from the ZFP recognition motif. This site, 1,250 bp upstream from the Fosb TSS, showed the greatest basal enrichment in H3K9me2 in both mouse and human NAc, and we found that, following ZFP-induced H3K9me2, binding of HP1a was increased only at this location. In non-nervous tissues, repression by H3K9me2 often involves not only the recruitment of HP1, but also generation of H3K9me3, and can spread to adjacent genomic regions 40, 41 . Given the widespread methylation induced by Fosb-ZFP35-G9a, we investigated H3K9me3 binding across the Fosb promoter and found, to our surprise, that this modification was depleted at the site of HP1a and H3K9me2 co-enrichment, with no regulation elsewhere in the Fosb promoter. We also measured DNA methylation at three CpGs located adjacent to this region, as DNA methyltransferase is also often recruited by HP1 and H3K9me2/3 (ref. 42 ), but did not find regulation of DNA methylation coincident with induced H3K9me2. Taken together, our results demonstrate a causal mechanism of gene repression at a euchromatic locus that is initiated by G9a recruitment, leading to enrichment of H3K9me2 and binding of HP1a, a mechanism of G9a/H3K9me2 action in fully differentiated adult neurons in vivo that differs from models based on other systems.
We next investigated a potential mechanism by which ZFP-induced H3K9me2 enrichment blocks cocaine-evoked Fosb expression in NAc. We found that this manipulation was sufficient to prevent the increase in phospho-CREB at the Fosb promoter, which is required for cocaineevoked Fosb/DFosb expression 32 and is known to be important for cellular and behavioral plasticity relevant to drug exposure 8 . Our results revealed no effect of H3K9me2 on the binding of total CREB or of phospho-SRF, indicating a specific action of H3K9me2 in preventing the phosphorylation of CREB already bound to Fosb. These results provide, to the best of our knowledge, the first direct evidence of a drug-evoked histone modification regulating gene expression by controlling transcription factor activity. Further studies will be needed to shed light on the mechanism by which H3K9me2 enrichment prevents CREB phosphorylation, especially given the ~1,000-bp distance between their binding sites.
Fosb has also been implicated in the cellular and behavioral correlates of stress and depression. In particular, previous studies have demonstrated that Fosb/DFosb expression in the NAc is deficient in the social isolation model of depression in mice and in this region of postmortem depressed patients, and that increased Fosb/∆Fosb expression in NAc protects animals from the deleterious effects of chronic stress 8 . To complement these data, we found that H3K9me2 was enriched at the FOSB promoter in NAc of depressed patients relative to controls, implicating this repressive epigenetic modification in the repression of FOSB in this population. Indeed, site 1,200 bp upstream from the TSS, coincident with the site of greatest H3K9me2 enrichment at the Fosb promoter in mouse NAc (Fig. 1g) . On the basis of these results, we examined the effect of artificially inducing H3K9me2 selectively at the Fosb gene in mouse NAc, thereby mimicking this single pathological histone modification in depressed humans. We relied on a variant of the chronic social defeat stress (CSDS) procedure, in which animals are subjected to a subthreshold social stress that has no effect on depression-related behaviors, such as social avoidance, in normal animals 36 . Mice were injected with HSV-Fosb-ZFP-G9a into NAc, allowed to recover for 5 d, and then exposed to an aggressor for three bouts of 5 min each (Fig. 4b) . In contrast with control virus, mice that were infected with HSV-Fosb-ZFP35-G9a showed reduced social interaction when tested 24 h after the aggressive encounter, a pro-depressionlike behavioral response (Fig. 4i) . Furthermore, we found that these mice spent less time exploring the open arms in the elevated plus maze, indicative of increased anxiety-related behavior (Fig. 3h) . Thus, mimicking a single HPTM abnormality seen at a single gene in the NAc of depressed humans is sufficient to promote behavioral susceptibility to stress.
DISCUSSION
We used engineered transcription factors to site-selectively remodel chromatin in a discrete brain region to control both the molecular and behavioral effects of drug and stress exposure. We targeted the Fosb gene because of its known role in the pathophysiology of drug addiction and depression in both rodents and humans, which has been linked to epigenetic remodeling at this locus. Specifically, drug-induced activation of Fosb is correlated with increased histone acetylation and decreased histone methylation at its promoter, yet it has not previously been possible to elucidate the functional relevance of such changes as a result of the genome-wide context in which they occur. To overcome this limitation, we designed a suite of engineered transcription factors that target the Fosb locus and applied them to the expression of Fosb/DFosb under both basal and cocaine-induced conditions. We found that Fosb-ZFPs and Fosb-TALEs fused to the transcriptional activators p65 or VP64, respectively, activated Fosb/DFosb expression in both cultured cells and when virally expressed in NAc. NAc expression of Fosb-ZFP35-p65 induced histone acetylation across the Fosb promoter, a modification that has been implicated in cocaine-induced activation of this locus 1 . We found that acetylation of Fosb by Fosb-ZFP35-p65 was sufficient to enhance the sensitizing effects of cocaine, indicating that ZFP-induced acetylation may act synergistically with cocaine-activation of this gene to produce an enhanced behavioral response. In a complementary procedure, we found that histone methylation by Fosb-ZFP35-G9a was sufficient to repress basal expression of Fosb/DFosb in vivo and block cocaine locomotor sensitization. These results represent, to the best of our knowledge, the first demonstration of ZFP-induced chromatin modifications in vivo and the first use of engineered transcription factors to elucidate transcriptional dysregulation underlying neuropsychiatric disease.
We included numerous control constructs in our study to rule out the effects of stoichiometric interference by ZFPs in the transcription of Fosb. We found that Fosb-ZFP35 without a functional domain did not affect Fosb/DFosb expression or chromatin modification in either the basal or cocaine contexts. To further establish the specificity of our engineered transcription factors in targeting Fosb selectively, we analyzed the regulation of 28 potential off-target binding motifs in vivo, each of which differs from the ZFP35 binding site by one to three nucleotides, and found no transcriptional regulation of their associated genes by Fosb-ZFP35-p65 or Fosb-ZFP35-G9a. In addition, we found no enrichment of H3K9me2 at six of these sites examined after expression of Fosb-ZFP35-G9a. Our results are consistent with a small number of in vitro studies that have examined ZFP or TALE specificity and concluded that there is little to npg we found that ZFP-induced enrichment of H3K9me2 at Fosb in mouse NAc was not only sufficient to reduce Fosb/∆Fosb expression, but also induced a pro-depressive state, as manifested by depression-and anxietylike behaviors after social stress. These data suggest a causal epigenetic mechanism for Fosb repression in the pathophysiology of depression.
In summary, we found that histone methylation or acetylation per se at the Fosb locus in the NAc is sufficient to dynamically regulate gene expression at this locus and thereby control the behavioral effects of cocaine or stress exposure. The ability to site-specifically modify chromatin enabled us to model a pathological epigenetic marker of human addiction and depression and observe the effects on drug and stress susceptibility in mice. Our findings also suggest that a primary change in H3K9me2 is sufficient to drive downstream changes in transcription factor binding and gene expression, which is in contrast with current models of HPTMs occurring mostly secondarily to alterations in transcription factors. By expanding this approach to target additional genes and HPTMs regulated by emotional stimuli, it will be possible to gradually build a detailed understanding of the epigenetic basis of addiction and depression.
METHODS
Methods and any associated references are available in the online version of the paper. and placed on ice. A fluorescence microscope (Leica) was used to visualize accurate NAc targeting of GFP-expressing virus and to accurately dissect only infected tissue. Dissections of NAc were taken with a 1-mm aluminum micropunch (Harris) and quickly frozen on dry ice until RNA was extracted. RNA isolation, qPCR and data analysis were performed as described 11 , using the primers listed in Supplementary Table 2. Data were analyzed by comparing C(t) values of the experimental virus with control virus using the DDC(t) method.
Western blotting. Frozen NAc tissue was homogenized in 30 µl of RIPA buffer containing 10 mM Tris, 150 mM NaCl, 1 mM EDTA, 0.1% SDS, 1% Triton X-100, 1% sodium deoxycholate and protease inhibitors (Roche) using an ultrasonic processor (Cole Parmer). Protein concentrations were determined using a DC protein assay (Bio-Rad), and 50 µg of protein were loaded onto 4-15% gradient Tris-HCl polyacrylamide gels for electrophoresis fractionation (Bio-Rad). Proteins were transferred to nitrocellulose membranes, blocked with Odyssey blocking buffer (Li-Cor) and incubated overnight at 4 °C with primary antibodies (FosB/DFosB, 1:500, Cell signaling 2551 (ref. 12); H3K9me2, 1:500, Abcam ab1220) 12 in Odyssey blocking buffer. After thorough washing with 1× Tris-buffered saline plus 0.1% Tween-20 (vol/vol), membranes were incubated with IRDye secondary antibodies (1:5,000 to 1:10,000, Li-Cor, 926-32213) dissolved in Odyssey blocking buffer for 1 h at 22-25 °C. For analysis, the blots were imaged with the Odyssey Infrared Imaging system (Li-Cor) and quantified by densitometry using ImageJ (US National Institutes of Health). The amount of protein blotted onto each lane was normalized to levels of actin (MP BioMedicals Clone C4). Representative image and data shown are from one experiment of two biological replicate experiments using two animal cohorts.
Immunohistochemistry, imaging and cell counting. Adult males were terminally anesthetized (chloral hydrate) and transcardially perfused with phosphate-buffered salien (PBS) followed by 4% paraformaldehyde (wt/vol). Brains were then post-fixed overnight in 4% paraformaldehyde at 4 °C, cryoprotected in 30% sucrose (wt/vol) at 4 °C until isotonic and stored at -80 °C. 35-µm coronal sections were sliced on a freezing microtome. Striatal sections were washed in PBS and blocked with 3% normal donkey serum (vol/vol, NDS) before incubating in primary antibody (rabbit antibody to FosB, 1:1,000, Santa Cruz Biotechnology sc-48 (ref. Technologies) . Slides were stored in a light-proof box at 4 °C before and after imaging. Slides were imaged on an Axio Observer Inverted Microscope (Zeiss) fitted with fluorescent filters. For each animal, 4-8 sections along the A-P axis of the NAc were imaged at 20× magnification (AxioVision imaging software, Zeiss) by an observer blind to conditions. For anatomical consistency, images included a portion of the anterior commissure as a marker of the NAc. Images were taken simultaneously for DAPI, GFP and FosB (Cy3). Adjustments were made as necessary to accurately capture fluorescent intensity. Analysis of FosB + cells was performed using ImageJ. In the red channel, threshold was adjusted to accurately count moderate-to highly expressing FosB + cells. An elliptical of a constant size selected a region of interest through the core and shell of the NAc, and particles were analyzed (size, 15-175; circularity, 0.01-1) for each image. Representative image and data shown are from one experiment of two technical replicate experiments, in which sections from the same cohort of animals were subject to immunohistochemical analysis.
ChIP. ChIP was performed on bilateral NAc 15-gauge punches pooled from 4-5 mice 72 h after viral infection or 24 h after the last drug treatment, and dissected as described above, or 5 × 10 6 N2a cells 48 h after transfection. Chromatin was prepared as described previously 1 and sheared using a diogenode bioruptor XL at high sonication intensity for 30 s on/ 30 s off for either 25 min twice. Fragment size was verified with an Agilent 2100 bioanalyzer at 150-300 bp or 1,000-3,000 bp respectively. Sheared chromatin was incubated overnight with the following
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Mice and treatments. Male 7-8-week-old C57BL/6J mice and 6-month-old CD1 retired breeders (CD1 aggressor) were housed at 22-25 °C in a 12-h light/ dark cycle and provided food and water ad libitum. Mice were housed five per cage and habituated in our facility for at least 1 week before experimentation, and all tests were conducted during the light cycle. Members of the same cage were randomly assigned to different experimental groups for behavioral studies and the order of testing was distributed across groups. Wherever possible, the experimenter conducting the data analysis was blind to treatment conditions of the animals. All experiments were conducted in accordance with the guidelines of the Institutional Animal Care and Use Committee at Mount Sinai. Group size determination was based on published protocols for the behavioral procedure in use; no statistical test was used to predetermine sample size. For repeated cocaine experiments (immunohistochemistry, ChIP), animals received daily injections of either saline (five treatments of saline, intraperitoneal) or saline followed by cocaine (one treatment of saline, four treatments of cocaine, 20 mg per kg, intraperitoneal) and were killed 24 h after the last injection. Sample size was determined based on empirical data in preliminary experiments and published protocols.
Transcription factor engineering. All ZFPs were manufactured by the CompoZr ZFN Operations Group at Sigma-Aldrich Biotechnology and cloned in frame N-terminal to the activation or repression domain. The ZFPs recognize the following unique 18-20-bp motifs in the Fosb promoter: ZFP1, TCC-GTGACAAAGCTAGTGG; ZFP14, ACCTTCTCCAACCCGGGT; ZFP25, CAACAGCGGGCGCGCGCAG; ZFP29, CCAAACAAACACTGGGCCGC; ZFP31,GGCCGCGCTGGCCGAGCTCC; ZFP35, GATCCCCTCCCGC-GAAGCC; ZFP54, TGCGGGTGACGCAAGCGCG; ZFP61, GCCGGGGA-CACGCGGAGCC; Klf4 promoter, GTGACCCGCGCCCATGGCC. All TALE constructs were generated as described previously 15 . Briefly, TALE binding sites, 18-nucleotide targets with T as the first base, were selected from the promoter region of Fosb. All TALE repeat arrays were constructed using modular assembly followed by insertion into cloning backbones containing the non-repetitive TALE capping regions and the VP64 transcription activator. The identities of repeat variable diresidues (RVDs) in each TALE repeat array are as follows (name, target site (5′ to 3′), repeat array RVDs) or published 33 Bioinformatics. Bowtie was used to align FosB-ZFP35 motif to mouse genome (mm9) 44 , and three mismatches at maximum was allowed (parameter: -v 3). Then, region_analysis.pl, a genome annotation utility in diffReps package 45 , was applied to annotate the hit regions with RefSeq database. Only the hits within 3 kb to TSSs were subject to further validation.
N2a transfection and RNA isolation. Neuro2a cells (ATCC CCL-131; manufacturer's authentication available online) were cultured and transfected with 400 ng of plasmid DNA using Effectene reagent (Qiagen), and RNA was isolated using the RNeasy Mini Kit (Qiagen) according to the manufacturer's instructions. qPCR and data analysis were performed as described 11 , using the primers listed in Supplementary Table 1. Data were analyzed by comparing C(t) values of the experimental construct with mock-transfected cells using the DDC(t) method. Viral-mediated gene transfer. Mice were anesthetized with a mixture of ketamine (100 mg per kg) and xylazine (10 mg per kg) and prepared for stereotaxic surgery. 33 gauge syringe needles (Hamilton) were used to bilaterally infuse 0.5-1.0 μl of virus into NAc at a rate of 0.1 μl min -1 at 1.6 mm A/P, +1.5 mm lateral and 4.4 mm D/V from Bregma. We used bicistronic p1005 HSV vectors expressing GFP alone or GFP plus Fosb-ZFP or Fosb-TALE. In this system, GFP expression is driven by a cytomegalovirus (CMV) promoter, whereas the select gene of interest is driven by the IE4/5 promoter 12 . As with other HSV vectors, we detected no change in neuronal viability with any of the vectors that we used.
NAc RNA isolation and qRT-PCR. 72 h after viral infection, when transgene expression was maximal, mice were rapidly decapitated and brains were removed npg Human postmortem brain tissue. Human postmortem brain tissue was obtained from the Dallas Brain Collection (DBC), where tissue is collected from the Dallas Medical Examiner's Office and the UT Southwestern Tissue Transplant Program after consent from the next of kin. Tissue was analyzed from 9 depressed patients (5 male, 4 female; age 44 ± 7, postmortem interval (PMI) 15 ± 2) and 18 controls (15 male, 3 female; age 51 ± 3; PMI 16 ± 1). The UT Southwestern Institutional Review Board reviewed and approved the collection of this tissue for research use. A direct informant interview was carried out for each depression sample at a later date, where information regarding the individual's illness was documented; a consensus diagnosis of major depressive disorder was made by psychiatrists using DSM-IV criteria. None of the samples included in the study had blood toxicology screens positive for drugs of abuse, alcohol or prescription drugs, including antidepressants. NAc dissection, tissue processing and chromatin preparation were performed as reported previously 52 . qChIP was performed using antibody to H3K9me2 antibody (ab1220, AbCam) previously bound to magnetic beads (Dynabeads M-280, Life Technologies). Analysis of relative enrichment was performed using qRT-PCR as described.
Statistics. The appropriate statistical test was determined based on the number of comparisons being done. Student's t tests were used for comparison of two groups, in the analysis of qRT-PCR, qChIP and social interaction data. One-way ANOVA was used for analysis of three or more experimental groups, with a Bonferroni correction test post hoc, when appropriate, in the analysis of mouse locomotor data. Main and interaction effects were considered significant at P < 0.05. Data are expressed as mean ± s.e.m. The Grubbs test was used when appropriate to identify outliers. F tests of variance were conducted on all data sets to ensure that the data followed a normal distribution. All experiments were carried out one to three times, and data replication was observed in instances of repeated experiments. Experimental sample sizes as indicated in the figure legends were determined to give the reported s.e.m. values that were sufficiently low to allow meaningful interpretation of the data.
A Supplementary Methods Checklist is available.
